BN · rank #2 · 2026-07-24
AIXA
XETRA · EUR · $5.18B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | 1.12 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +34.6% |
| Forward net margin Consensus forward net margin. | +15.3% |
| Net margin TTM Trailing twelve month net margin. | +11.6% |
| Margin expansion Forward minus trailing net margin (percentage points). | +3.7% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | 2.08 |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 0.04× |
| Analyst upside Spread between the consensus 12m target and the current price. | +28.4% |
| Last EPS surprise Most recent reported EPS versus consensus. | -171% |
| Market cap (USD) | $5.18B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
AIXTRON SE (AIXA@XETRA) makes specialized MOCVD/epitaxy deposition tools for compound semiconductors used in GaN, SiC, and optoelectronic applications.
Rationale
The bottleneck-solver setup looks credible because AIXTRON sits in a highly qualified, hard-to-switch tool niche, and the Q1 order surge plus raised FY26 guidance signal that demand visibility is returning despite a weak shipment quarter.
Material risks
- 1The biggest thesis-breaker is customers or competitors qualifying alternative epitaxy vendors or building more of the process in-house, which would erode AIXTRON’s bottleneck status and pricing power.
- 2SiC/GaN and optoelectronics capex remains cyclical, and export controls or China-related shipment frictions could again delay orders or leave capacity underutilized.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 1 of 3 voted to proceed.